Cargando…
Glycosylation Changes in Prostate Cancer Progression
Prostate Cancer (PCa) is the most commonly diagnosed malignancy and second leading cause of cancer-related mortality in men. With the use of next generation sequencing and proteomic platforms, new biomarkers are constantly being developed to both improve diagnostic sensitivity and specificity and he...
Autores principales: | Butler, William, Huang, Jiaoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739790/ https://www.ncbi.nlm.nih.gov/pubmed/35004332 http://dx.doi.org/10.3389/fonc.2021.809170 |
Ejemplares similares
-
Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure
por: Hu, Chang-Deng, et al.
Publicado: (2015) -
Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With “Gray-Zone PSA” and Inhibits Cancer Progression via Regulating Glycosylation
por: Zhang, Cong, et al.
Publicado: (2021) -
Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms
por: Butler, William, et al.
Publicado: (2021) -
Editorial: Glycosylation Changes in Cancer: An Innovative Frontier at the Interface of Cancer and Glycobiology
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2016) -
Glycosylated Notch and Cancer
por: Pakkiriswami, Shanmugasundaram, et al.
Publicado: (2016)